Boosting half-life and effector functions of therapeutic antibodies by Fc-engineering: An interaction-function review.
Sign Up to like & getrecommendations! Published in 2018 at "International journal of biological macromolecules"
DOI: 10.1016/j.ijbiomac.2018.07.141
Abstract: Due mainly to their high level of affinity and specificity, therapeutic monoclonal antibodies (mAbs) have been frequently selected as treatment for cancer, autoimmune or chronic inflammatory diseases. Despite the increasing number of mAbs and related… read more here.
Keywords: life effector; engineering; half life; antibody ... See more keywords